Cytosorbents Corp (CTSO.OQ)
7.70USD
20 Apr 2018
$-0.05 (-0.65%)
$7.75
$7.75
$7.80
$7.68
5,084
22,122
$8.32
$3.35
Latest Key Developments (Source: Significant Developments)
Cytosorbents Sees Q4 2017 Revenue About $4.6 Million
Jan 8 (Reuters) - Cytosorbents Corp
U.S. FDA Approves Cytosorbents' Refresh 2 IDE Application With Conditions
Dec 21 (Reuters) - Cytosorbents Corp
Cytosorbents posts Q3 revenue of $3.8 mln
Nov 9 (Reuters) - Cytosorbents Corp
CytoSorbents signs deal with Armaghan Salamat Kish Group to distribute CytoSorb in Iran
CytoSorbents Corp
Cytosorbents achieves fourth consecutive quarter of record Cytosorb sales
Cytosorbents Corp
Cytosorbents teams with Medial and Meditrade to bring CytoSorb to Hungary, Czech Republic, Slovakia, and Poland
Cytosorbents Corp
CytoSorbents says independent monitoring board recommends continuation of REFRESH I trial
CytoSorbents Corp
Cytosorbents says total revenue for Q1 was $1.8 million
Cytosorbents Corp
BRIEF-Cytosorbents Refinances Existing Debt With New $15 Mln Debt Facility With Bridge Bank
* CYTOSORBENTS REFINANCES EXISTING DEBT WITH NEW $15 MILLION DEBT FACILITY WITH BRIDGE BANK